Preparation and evaluation of niosomes containing autoclaved Leishmania major: a preliminary study

References

• Alimohammadian MH, Khamesipour A, Darabi H, Firooz A, Malekzadeh S, Bahonar A, Dowlati Y, Modabber F. The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis. Vaccine 2002; 21: 174–80
   PubMed Web of Science ®Google Scholar
• Ambrosch F, Wiedermann G, Jonas S, Althaus B, Finkel B, Glück R, Herzog C. Immunogenicity and protectivity of a new liposomal hepatitis A vaccine. Vaccine 1997; 15: 1209–13
   PubMed Web of Science ®Google Scholar
• Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. The preparation and properties of niosomes – non ionic surfactant vesicles. J Pharm Pharmacol 1985; 37: 863–8
   PubMed Web of Science ®Google Scholar
• Brewer JM, Alexander J. The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin. Immunology 1992; 75: 570–5
   PubMed Web of Science ®Google Scholar
• Chattaraj SC, Das SK. Physicochemical characterization of influenza viral vaccine loaded surfactant vesicles. Drug Deliv 2003; 10: 73–7
   PubMed Web of Science ®Google Scholar
• Christensen D, Korsholm KS, Andersen P, Agger EM. Cationic liposomes as vaccine adjuvants. Exp Rev Vaccines 2011; 10: 513–21
   PubMed Web of Science ®Google Scholar
• Conacher M, Alexander J, Brewer JM. Niosomes as immunological adjuvant. Synthetic surfactant vesicles, IF Uchegbu. International Publishers Distributors Ltd, Singapore 2000a; 185–205
   Google Scholar
• Conacher M, Alexander J, Brewer JM. Niosomes as immunological adjuvants. Drug Target Deliv 2000b; 11: 185–206
   Google Scholar
• Gregoriadis G, Gursel I, Gursel M, McCormack B. Liposomes as immunological adjuvants and vaccine carriers. J Controlled Release 1996; 41: 49–56
   Web of Science ®Google Scholar
• Henriksen-Lacey M, Korsholm KS, Andersen P, Perrie Y, Christensen D. Liposomal vaccine delivery systems. Expert Opin Drug Deliv 2011; 8: 505–19
   PubMed Web of Science ®Google Scholar
• Huang Y, Rao Y, Chen J, Yang VC, Liang W. Polysorbate cationic synthetic vesicle for gene delivery. J Biomed Mater Res A 2011; 96A: 5131–9
   Google Scholar
• Jain S, Vyas SP. Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J Liposome Res 2006; 16: 331–45
   PubMed Web of Science ®Google Scholar
• Jesorka A, Orwar O. Liposomes: Technologies and analytical applications. Annu Rev Anal Chem 2008; 1: 801–32
   PubMed Web of Science ®Google Scholar
• Karim KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M, Kuotsu K. Niosome: A future of targeted drug delivery systems. J Adv Pharm Technol Res 2010; 1: 374–80
   PubMedGoogle Scholar
• Kenney RT, Sacks DL, Sypek JP, Vilela L, Gam AA, Evans-Davis K. Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. J Immunol 1999; 163: 4481–8
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, Chauhan S, Lawrence SM, Barlow DJ. The formation, characterization and stability of non-ionic surfactant vesicles. STP Pharm Sci 1996; 6: 49–60
   Google Scholar
• Lindblad EB. Aluminium compounds for use in vaccines. Immunol Cell Biol 2004; 82: 497–505
   PubMed Web of Science ®Google Scholar
• Manconi M, Sinico C, Valenti D, Loy G, Fadda AM. Niosomes as carriers for tretinoin. Preparation and properties. Int J Pharm 2002; 234: 237–48
   PubMed Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, Abe M. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B 2003; 30: 129–38
   Web of Science ®Google Scholar
• Mishra J, Saxena A, Singh S. Chemotherapy of leishmaniasis: Past, present and future. Curr Med Chem 2007; 14: 1153–69
   PubMed Web of Science ®Google Scholar
• Misra A, Dube A, Srivastava B, Sharma P, Srivastava JK, Katiyar JC, Naik S. Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG. Vaccine 2001; 19: 3485–92
   PubMed Web of Science ®Google Scholar
• Murdan S, Gregoriadis G, Florence AT. Sorbitan monostearate/polysorbate 20 organogels containing niosomes: A delivery vehicle for antigens. Eur J Pharm Sci 1999; 8: 177–85
   PubMed Web of Science ®Google Scholar
• Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet 2005; 366: 1561–77
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Kunisawa J, Hayashi A, Tsutsumi Y, Kubo K, Nakagawa S, Fujiwara H, Hamaoka T, Mayumi T. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem Biophys Res Commun 1997; 240: 793–7
   PubMed Web of Science ®Google Scholar
• Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 2007; 328: 130–41
   PubMed Web of Science ®Google Scholar
• Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW. Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens. Int J Pharm 2008; 364: 272–80
   PubMed Web of Science ®Google Scholar
• Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis 2007; 7: 581–96
   PubMed Web of Science ®Google Scholar
• Rhee EG, Mendez S, Shah JA, Wu C, Kirman JR, Turon TN, Davey DF, Davis H, Klinman DM, Coler RN. Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection. J Exp Med 2002; 195: 1565–73
   PubMed Web of Science ®Google Scholar
• Roberts CW, Brewer JM, Alexander J. Congenital toxoplasmosis in the Balb/c mouse: Prevention of vertical disease transmission and fetal death by vaccination. Vaccine 1994; 12: 1389–94
   PubMed Web of Science ®Google Scholar
• Sharifi I, Fekri AR, Aflatonian MR, Khamesipour A, Nadim A, Mousavi MRA, Momeni AZ, Dowlati Y, Godal T, Zicker F. Randomized vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet 1998; 351: 1540–3
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 1998; 172: 33–70
   Web of Science ®Google Scholar
• Varshosaz J, Pardakhty A, Hajhashemi V, Najafabadi AR. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv 2003; 10: 251–62
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Pardakhty A, Mohsen S, Baharanchi H. Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate. Drug Deliv 2005; 12: 75–82
   PubMed Web of Science ®Google Scholar
• Vogel FR, Powell MF. A compendium of vaccine adjuvants and excipients. Pharm Biotechnol 1995; 6: 141–228
   PubMedGoogle Scholar
• Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm 1994; 105: 1–6
   Web of Science ®Google Scholar